Yes, perform STI testing immediately in this patient.
This 16-year-old sexually active female with inconsistent condom use meets clear criteria for immediate chlamydia and gonorrhea screening, regardless of her URI symptoms. The amenorrhea and low BMI require evaluation but should not delay STI testing.
Primary Rationale for Immediate STI Testing
The American Academy of Pediatrics and multiple guidelines recommend routine annual screening for chlamydia and gonorrhea in all sexually active females aged 25 years or younger 1, 2. Your patient meets this criterion based on:
- Age 16 years (within screening age)
- Sexually active status (implied by inconsistent condom use)
- High-risk behavior: inconsistent condom use is specifically identified as a risk factor warranting screening 2
The ACOG guidelines explicitly list "inconsistent condom use" as a high-risk factor for gonorrhea screening in asymptomatic women 2.
Testing Should Include
- Chlamydia trachomatis (routine screening indicated)
- Neisseria gonorrhoeae (high-risk factors present)
- Pregnancy test (essential given amenorrhea and sexual activity - 68.5% of eligible females in ED settings receive this 3)
- Consider HIV and syphilis screening based on local prevalence and individual risk assessment 1
Critical Clinical Context
The Amenorrhea Component
The 3-month amenorrhea with BMI 15.8 (significantly underweight) suggests possible:
- Pregnancy (must rule out immediately)
- Hypothalamic amenorrhea from low body weight
- Other endocrine causes
However, pregnancy testing is urgent and STI screening should occur concurrently, not sequentially. These are parallel, not competing priorities.
Common Pitfall to Avoid
Do not delay STI testing while working up the amenorrhea. Research shows that only 37.8% of ED patients with STI-suggestive symptoms undergo testing 3, and only 56% have sexual history documented 4. Among those tested, 25% are positive for an STI 4. Missing this opportunity perpetuates underdiagnosis.
The URI Symptoms
The upper respiratory symptoms are likely unrelated to STI concerns but do not preclude testing. Many STIs are asymptomatic 5, and this patient's risk profile—not her presenting complaint—drives the screening indication.
Testing Logistics
- Urine-based nucleic acid amplification tests (NAATs) are highly sensitive and specific, making testing straightforward and non-invasive 5
- Can be performed during the same visit as URI evaluation
- Results guide need for treatment and partner notification
Additional Considerations
If testing is positive, rescreen 3 months after treatment regardless of partner treatment status due to high reinfection rates in adolescents (median reinfection time 4.7-7.6 months) 1, 5. Consider screening every 6 months for sexually active adolescents with ongoing risk 5.
The presence of any STI increases risk for other STIs, and evaluation for HIV should be considered if initial testing is positive 1.